Dabigatran versus warfarin in the treatment of acute venous thromboembolism. Results of the RE-COVER study
Liakishev, A.A.
Kardiologiia 50(3): 80-81
2010
ISSN/ISBN: 0022-9040 PMID: 20459411 Document Number: 647853
Document emailed within 1 workday
Related Documents
Liakishev, A.A. 2009: Dabigatran versus Warfarin in patients with atrial fibrillation. Results of the RE-LY study Kardiologiia 49(10): 75-76Egermayer, P.; Inder, A.; Town, G.I. 2001: The use of warfarin in Christchurch for the treatment of venous thromboembolism New Zealand Medical Journal 114(1136): 336-338
Yang, P.; Wu, Q.-H.; Luo, X.-Y.; Kou, L.; Chen, Z.; Zhang, Y.-Y.; Zhou, H. 2009: The study of Chinese optimal anticoagulant range of warfarin for venous thromboembolism Zhonghua Yi Xue Za Zhi 89(25): 1762-1765
Bonarelli, S.; Bacchin, M.R.; Frugiuele, I.; Feoli, M.A.; Facchini, F.; Altimari, V. 2015: Dabigatran etexilate and LMWH for the prevention of venous thromboembolism in 532 patients undergoing hip surgery European Review for Medical and Pharmacological Sciences 19(5): 897-903
Walker, A.; Campbell, S.; Grimshaw, J. 1999: Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group Health Bulletin 57(2): 141-147
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967
Heit, J.A.; Berkowitz, S.D.; Bona, R.; Cabanas, V.; Corson, J.D.; Elliott, C.G.; Lyons, R. 1997: Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group Thrombosis and Haemostasis 77(1): 32-38
Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
Spencer, F.A.; Gore, J.M.; Reed, G.; Lessard, D.; Pacifico, L.; Emery, C.; Crowther, M.A.; Goldberg, R.J. 2009: Venous thromboembolism and bleeding in a community setting. the Worcester Venous Thromboembolism Study Thrombosis and Haemostasis 101(5): 878-885
Carter, B.L. 1991: Therapy of acute thromboembolism with heparin and warfarin Clinical Pharmacy 10(7): 503-518
Gensini, G.F.; Rostagno, C.; Caciolli, S. 1998: Treatment options for acute venous thromboembolism in the older patient Geriatrics 53(1): 34-36; 39-40; 46-47
Worthington, J.M.; Gattellari, M. 2009: Dabigatran versus warfarin in patients with atrial fibrillation New England Journal of Medicine 361(27): 2672-2673; Author Reply 2674-2675
Emmerich, J.; Rosendaal, F.R.; Cattaneo, M.; Margaglione, M.; De Stefano, V.; Cumming, T.; Arruda, V.; Hillarp, A.; Reny, J.L. 2001: Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism Thrombosis and Haemostasis 86(3): 809-816
2012: Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients Prescrire international 21(124): 33-36
Betancourt, M.T.; Rodger, M.A. 2007: Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients Acta Chirurgica Belgica 107(6): 636-640
Burnayeva, S.V.; Vasilyeva, I.I.; Gavrisyuk, V.K.; Gerasimenko, S.I.; Gudz, I.M.; Dzyublik, A.Ya.; Dzyak, G.V.; Zharinov, O.I.; Kobza, I.I.; Kovalev, A.A.; Kolesnik, E.A.; Kostylev, M.V.; Kulik, I.V.; Lutay, Y.M.; Mishalov, V.G.; Mishchenko, T.S.; Nikonenko, A.S.; Nikonenko, A.A.; Nikulnikov, P.I.; Parkhomenko, A.N.; Polulyakh, M.V.; Rudenko, K.V.; Skupoy, O.M.; Tatarchuk, T.F.; Todurov, B.M.; Usenko, A.Yu.; Feshchenko, Y.I.; Chernukha, I.M.; Yachnik, A.I. 2017: The Experts Consensus for Anticoagulant Therapy of Venous Thromboembolism in 2016 Yr. Significance of the Rivaroxaban Investigations Program for Changes of Approaches, Concerning Treatment of the Deep Veins Thrombosis and Pulmonary Thromboembolism Klinichna Khirurhiia 2017(3): 65-80
Liu, F-fang.; Zhai, Z-guo.; Yang, Y-hua.; Wang, J.; Wang, C. 2013: Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism Zhonghua Yi Xue Za Zhi 93(24): 1860-1863
Kirienko, A.I.; Zolotukhin, I.A. 1998: Clexane in prevention of acute venous thrombosis and pulmonary thromboembolism Terapevticheskii Arkhiv 70(11): 78-80
Lyons, O.; Loh, J.; Lim, M.; O'Riordan, D.; Silke, B. 2013: Venous thromboembolism prophylaxis in acute medical admissions to a university teaching hospital Irish Medical Journal 106(8): 235-238
Comp, P.C. 1999: Advances in the etiology and treatment of venous thromboembolism Advances in Internal Medicine 44: 59-89